| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.35 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.32 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.29 | 2e-07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.29 | 0.04 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.28 | 3e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.28 | 3e-13 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.26 | 2e-12 |